TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Blood Flow Data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of Gas Vaporized Anesthetic Per Minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite of cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of daily physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Reoccurrence
Endpoint domain: Mortality/survival
Primary endpoint: 5-year cumulative incidence of hepatocellular carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Corrected QT interval (QTc) differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30 STS test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent days abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of TB treatment initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Growth of intestinal stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Expression and phosphorylation of signaling proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood and urine metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Ipsilateral Shoulder Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants With Negative Fungal Culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient - physician communication score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Experienced at Least One Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Markedly Abnormal Criteria for Clinical Laboratory Values at Least Once Postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Markedly Abnormal Criteria for Vital Signs at Least Once Postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Meet the Markedly Abnormal Values of 12-lead Electrocardiogram (ECG) Parameters at Least Once Post Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum HBsAg levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with iron metabolism gene mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complete gastric emptying of radioactive marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complete tablet breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motility of spermatozoides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of severe visual distortions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute SonRtip Lead Complication-Free Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Chronic SonRtip Lead Complication-Free Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Report deaths from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Telephonic-MoCA (t-MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of patients completed 16 week measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patient-reported barriers to technology of text messages
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concentration of sCD-163
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in Verbal and Physical Aggression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in Substance Abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Negative Parenting Behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Identification of biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Airway obstruction measured by FEV6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Composite of cardiac death, myocardial infarction, and target lesion revascularisation
Endpoint domain: Mortality/survival
Primary endpoint: Clinical consequences of Covid-19 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Stone Recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Successful delivery of anaesthetic techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Insulin Sensitivity Index (SI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute Insulin Resistance to Intravenous Glucose (AIRg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infarct growth measured by lesion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal Muscle Hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of passages through each part of the stair cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of low-salt cream soup and normal clear soup cups sold
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of low-fat and normal croissants sold
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of low-fat margarine servings and butter servings sold
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Score for the SFQ questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Score for the IIEF questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Gut beta-amyloid 42 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Primary outcome 1
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Primary outcome 2
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Response rate of retinoblastoma to topotecan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Local (ocular) toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Tongue strength change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbial diversity of stool samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Transport times from ambulance to CT Scout image recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Margin-negative (R0) Resection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Genetic polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eq-5d index scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Overnight Growth Hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of HIV+ Subjects With Any and Grade 3 Solicited Local Symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: HIV Viral Load (VL) in HIV+ Subjects at Month 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cluster of Differentiation 4 (CD4+) Cell Count in HIV+ Subjects at Month 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Requirement for oxygen therapy to maintain saturation >93%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Work productivity (daily weight of tea picked)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from Patient enablement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of subjects with colorectal cancer
Endpoint domain: Mortality/survival
Primary endpoint: Number of subjects with esophageal cancer
Endpoint domain: Mortality/survival
Primary endpoint: Number of subjects with gastric cancer
Endpoint domain: Mortality/survival
Primary endpoint: Serum specific IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum specific IgM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Mn levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and tolerability of oral doses of levodopa and carbidopa
Endpoint domain: Adverse events/effects
Primary endpoint: number of participants with abnormal results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in serum alkaline phosphatase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Removal of plasma protein-bound uremic toxins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CSF acetylcholine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of nosocomial infections
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormalities at onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pigmented conjunctival lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory responses (erythema and local skin reactions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Superficial effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Size of HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement of the AVA and NYHA Functional Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cartilage Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pattern electroretinogram response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: treatment adherence
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Development of osteonecrosis of the jaw (ONJ) or incomplete healing
Endpoint domain: Adverse events/effects
Primary endpoint: Change in patients health related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in panic symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non coding RNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and efficacy of CD133+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hamilton Depression Rating Scale-Maier Subscale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: de novo lipogenesis (DNL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatic triglyceride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who require anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Falls Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Estimated Contrast Sensitivity in Log Units (logCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported analgesic use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Active knee extension/flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Post procedural UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Resistant UTI
Endpoint domain: Adverse events/effects
Primary endpoint: Lipo-PGE1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of new chronic lung disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Symptoms Based on PAC-SYM and Wexner Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of subjects with parasitemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Use of Risk Reduction Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Total Sleep Time (TST)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Static Balance Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed and Up and Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-minute Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-spot Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Short Physical Performance Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Simulation Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized Uptake Value (SUV) of 18F-FDG and 18F-FLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RECIST 1.1 tumor size measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of patients treated with specific therapeutic intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of deceased patients
Endpoint domain: Mortality/survival
Primary endpoint: Successful nasal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in calculus index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Selective Mutism Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anxiety Disorders Interview Schedule (ADIS) Severity Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: photoreceptor density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to tuberculosis treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in Mean Spasticity NRS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SANS reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-Index Culprit Lesion Related Major Adverse Cardiac Events (NC-MACE)
Endpoint domain: Mortality/survival
Primary endpoint: Personal Well-Being Index (PWI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of C16G2 Gel administrations
Endpoint domain: Adverse events/effects
Primary endpoint: Change in fibroscan score (Kpa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ALT (U/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Number of Patients With Hidradenitis Suppurativa Clinical Response (HiSCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximum tolerated Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic appearance of scars
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma levels of Ethinyl Estradiol and Norelgestromin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration of BIIB104
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Observed Concentration of BIIB104
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve Within a Dosing Interval (AUCtau) of BIIB104
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cut-Point levels of FXIII
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose limiting toxicities (DLTs) BJ-001 as a single agent
Endpoint domain: Adverse events/effects
Primary endpoint: Dose limiting toxicities (DLTs) BJ-001 in combination with pembrolizumab inhibitor
Endpoint domain: Adverse events/effects
Primary endpoint: Number of apoptotic endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Angles of elbow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation of Anaesthesia Electronic Medical Record
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of rest-activity patterns
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: New Ischemic Stroke and Covert Brain Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Psoriasis Area Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pruritus Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of patients developing venous thromboembolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: CAHPS Communication Subscale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: State-Trait Anxiety Inventory Form Y
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean value and dispersion of pharmacokinetics parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Kshar sutra in Fistula in ano
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CMV blood viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: FEV1 on pulmonary function testing for breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FVC on pulmonary function testing for breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyspnea scores based on mMRC
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Specific binding ratio of dopamine transporter availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma concentrations of TMC207
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First Hospitalization for worsening Heart Failure
Endpoint domain: Mortality/survival
Primary endpoint: Microcirculatory flux in the lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of ulcer size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity after the first dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post Procedural Urinary Tract Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of CPX-351
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ICIQ-UI SF score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with complete anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in SMAF score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in Scores on Maslach Burnout Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in health as measured by scores on the RAND Short-Form 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in fatigue as measured by the Iowa Fatigue Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in mental health symptoms measured by the Depression/Anxiety/Stress Scale (21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sensitivity of swabbing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes